Company Website: http://maculogix.com
MacuLogix is a pioneer in the early detection and tracking of age-related macular degeneration (AMD). MacuLogix’ AdaptDx has received FDA 510(k) clearance for measurement of dark adaptation function and patient testing has been completed to support validation as a diagnostic for AMD. However, the AdaptDx is not currently cleared for sale as a diagnostic. In addition, the AdaptDx is being used by a number of pharmaceutical companies in the development of drugs for early AMD.